In-Depth Analysis of GLP-1 Nutritional Support Market in India The CAGR value moved up from nearly 11.3% in 2020 to 2024 to 16.8% for 2025 to 2035, supported by growth in private metabolic clinics and broader primary care integration
Kupfersztain C, Rotem C, Fagot R, Kaplan B
What causes tiny red dots that do not itch
At week 52, tirzepatide demonstrated superior results compared to dulaglutide, with significant reductions in HbA1c levels
Am I prepared to combine any product with lifestyle modifications
As daily injections are a barrier for some patients with T2D, there was focus on improving convenience, ideally with an effective GLP-1 analog that could be administered once weekly